Gene Kim

No más puestos en curso

48 años

Health Technology

Consumer Services

Perfil

Gene Kim worked as an Executive Director-Financial Planning & Analysis at Versartis, Inc. from 2013 to 2018.
He then served as a Vice President-Finance at Kaleido Biosciences, Inc. from 2018 to 2020.
Currently, he holds the position of Vice President-Finance at Dyne Therapeutics, Inc. Mr. Kim completed his undergraduate degree at the University of California, Los Angeles.

Antiguos cargos conocidos de Gene Kim.

Empresas	Cargo	Fin
KALEIDO BIOSCIENCES, INC.	Corporate Officer/Principal	01/01/2020
Versartis, Inc. Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.	Corporate Officer/Principal	01/05/2018
DYNE THERAPEUTICS, INC.	Director of Finance/CFO	-

Ver el detalle de la experiencia de Gene Kim.

Formación de Gene Kim.

University of California, Los Angeles

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Gene Kim.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
KALEIDO BIOSCIENCES, INC.	Health Technology
DYNE THERAPEUTICS, INC.	Health Technology

Empresas privadas	1
Versartis, Inc. Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.	Health Technology